|
1
|
Cai J, Chen H, Lu M, Zhang Y, Lu B, You L,
Zhang T, Dai M and Zhao Y: Advances in the epidemiology of
pancreatic cancer: Trends, risk factors, screening, and prognosis.
Cancer Lett. 520:1–11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sinha V, Shinde S, Saxena S, Thakur S,
Walia T, Dixit V, Tiwari AK, Vishvakarma NK, Dwivedi M and Shukla
D: A comprehensive review of diagnostic and therapeutic strategies
for the management of pancreatic cancer. Crit Rev Oncog.
25:381–404. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pannala R, Basu A, Petersen GM and Chari
ST: New-onset diabetes: A potential clue to the early diagnosis of
pancreatic cancer. Lancet Oncol. 10:88–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pelaez-Luna M, Takahashi N, Fletcher JG
and Chari ST: Resectability of presymptomatic pancreatic cancer and
its relationship to onset of diabetes: A retrospective review of CT
scans and fasting glucose values prior to diagnosis. Am J
Gastroenterol. 102:2157–2163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boursi B, Finkelman B, Giantonio BJ,
Haynes K, Rustgi AK, Rhim AD, Mamtani R and Yang YX: A clinical
prediction model to assess risk for pancreatic cancer among
patients with new-onset diabetes. Gastroenterology. 152:840–850.e3.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aurrand-Lions M, Galland F, Bazin H,
Zakharyev VM, Imhof BA and Naquet P: Vanin-1, a novel GPI-linked
perivascular molecule involved in thymus homing. Immunity.
5:391–405. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martin F, Malergue F, Pitari G, Philippe
JM, Philips S, Chabret C, Granjeaud S, Mattei MG, Mungall AJ,
Naquet P, et al: Vanin genes are clustered (human 6q22-24 and mouse
10A2B1) and encode isoforms of pantetheinase ectoenzymes.
Immunogenetics. 53:296–306. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pitari G, Malergue F, Martin F, Philippe
JM, Massucci MT, Chabret C, Maras B, Duprè S, Naquet P and Galland
F: Pantetheinase activity of membrane-bound Vanin-1: Lack of free
cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett.
483:149–154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dammanahalli KJ, Stevens S and Terkeltaub
R: Vanin-1 pantetheinase drives smooth muscle cell activation in
post-arterial injury neointimal hyperplasia. PLoS One.
7:e391062012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang H, Dong X, Kang MX, Xu B, Chen Y,
Zhang B, Chen J, Xie QP and Wu YL: Novel blood biomarkers of
pancreatic cancer-associated diabetes mellitus identified by
peripheral blood-based gene expression profiles. Am J
Gastroenterol. 105:1661–1669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang M, Qin W, Buya M, Dong X, Zheng W, Lu
W, Chen J, Guo Q and Wu Y: VNN1, a potential biomarker for
pancreatic cancer-associated new-onset diabetes, aggravates
paraneoplastic islet dysfunction by increasing oxidative stress.
Cancer Lett. 373:241–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau
JS, Bhattacharya S, Truty M, Petersen GM, Kaufman RJ, Chari ST and
Mukhopadhyay D: Pancreatic cancer-derived exosomes cause
paraneoplastic β-cell dysfunction. Clin Cancer Res. 21:1722–1733.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Zhang B, Zheng W, Kang M, Chen Q,
Qin W, Li C, Zhang Y, Shao Y and Wu Y: Exosomes derived from
pancreatic cancer cells induce insulin resistance in C2C12 myotube
cells through the PI3K/Akt/FoxO1 pathway. Sci Rep. 7:53842017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk
TC, Lau JS, Giorgadze N, Tchkonia T, Kirkland JL, Chari ST and
Mukhopadhyay D: Pathogenesis of pancreatic cancer exosome-induced
lipolysis in adipose tissue. Gut. 65:1165–1174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Huang S, Li P, Chen Q, Li Y, Zhou
Y, Wang L, Kang M, Zhang B, Yang B, et al: Pancreatic
cancer-derived exosomes suppress the production of GIP and GLP-1
from STC-1cells in vitro by down-regulating the PCSK1/3. Cancer
Lett. 431:190–200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sah RP, Nagpal SJ, Mukhopadhyay D and
Chari ST: New insights into pancreatic cancer-induced
paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol. 10:423–433.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai H, Yang B, Xu Z, Zhang B, Xu B, Li X,
Wu P, Chen K, Rajotte RV, Wu Y and Rayat GR: Cyanidin-3-O-glucoside
enhanced the function of syngeneic mouse islets transplanted under
the kidney capsule or into the portal vein. Transplantation.
99:508–514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rayat GR, Gazda LS, Hawthorne WJ, Hering
BJ, Hosking P, Matsumoto S and Rajotte RV: First update of the
international xenotransplantation association consensus statement
on conditions for undertaking clinical trials of porcine islet
products in type 1 diabetes-chapter 3: Porcine islet product
manufacturing and release testing criteria. Xenotransplantation.
23:38–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berruyer C, Martin FM, Castellano R,
Macone A, Malergue F, Garrido-Urbani S, Millet V, Imbert J, Duprè
S, Pitari G, et al: Vanin-1-/- mice exhibit a glutathione-mediated
tissue resistance to oxidative stress. Mol Cell Biol. 24:7214–7224.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang B, Lo C, Shen L, Sood R, Jones C,
Cusmano-Ozog K, Park-Snyder S, Wong W, Jeng M, Cowan T, et al: The
role of vanin-1 and oxidative stress-related pathways in
distinguishing acute and chronic pediatric ITP. Blood.
117:4569–4579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berruyer C, Pouyet L, Millet V, Martin FM,
LeGoffic A, Canonici A, Garcia S, Bagnis C, Naquet P and Galland F:
Vanin-1 licenses inflammatory mediator production by gut epithelial
cells and controls colitis by antagonizing peroxisome
proliferator-activated receptor gamma activity. J Exp Med.
203:2817–2827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ryu S, Ornoy A, Samuni A, Zangen S and
Kohen R: Oxidative stress in Cohen diabetic rat model by
high-sucrose, low-copper diet: Inducing pancreatic damage and
diabetes. Metabolism. 57:1253–1261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Robertson RP, Harmon J, Tran PO, Tanaka Y
and Takahashi H: Glucose toxicity in beta-cells: Type 2 diabetes,
good radicals gone bad, and the glutathione connection. Diabetes.
52:581–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Piro S, Anello M, Di Pietro C, Lizzio MN,
Patanè G, Rabuazzo AM, Vigneri R, Purrello M and Purrello F:
Chronic exposure to free fatty acids or high glucose induces
apoptosis in rat pancreatic islets: Possible role of oxidative
stress. Metabolism. 51:1340–1347. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Veeraperumal S, Zhong S and Cheong
KL: Fucoidan-derived functional oligosaccharides: Recent
developments, preparation, and potential applications. Foods.
12:8782023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pezzilli R and Pagano N: Is diabetes
mellitus a risk factor for pancreatic cancer? World J
Gastroenterol. 19:4861–4866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang F, Larsson J, Adrian TE, Gasslander T
and Permert J: In vitro influences between pancreatic
adenocarcinoma cells and pancreatic islets. J Surg Res. 79:13–19.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Basso D, Brigato L, Veronesi A, Panozzo
MP, Amadori A and Plebani M: The pancreatic cancer cell line MIA
PaCa2 produces one or more factors able to induce hyperglycemia in
SCID mice. Anticancer Res. 15:2585–2588. 1995.PubMed/NCBI
|
|
30
|
Bonnefont-Rousselot D, Bastard JP, Jaudon
MC and Delattre J: Consequences of the diabetic status on the
oxidant/antioxidant balance. Diabetes Metab. 26:163–176.
2000.PubMed/NCBI
|
|
31
|
Kaneto H, Katakami N, Kawamori D,
Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M and Yamasaki Y:
Involvement of oxidative stress in the pathogenesis of diabetes.
Antioxid Redox Signal. 9:355–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Butler PC, Meier JJ, Butler AE and Bhushan
A: The replication of beta cells in normal physiology, in disease
and for therapy. Nat Clin Pract Endocrinol Metab. 3:758–768. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bensellam M, Jonas JC and Laybutt DR:
Mechanisms of β-cell dedifferentiation in diabetes: Recent findings
and future research directions. J Endocrinol. 236:R109–R143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang C, Su H, Zhang D, Wang Y, Shen Q,
Liu B, Huang R, Zhou T, Peng C, Wong CC, et al: AMPK-dependent
phosphorylation of GAPDH triggers Sirt1 activation and is necessary
for autophagy upon glucose starvation. Mol Cell. 60:930–940. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakae J, Cao Y, Daitoku H, Fukamizu A,
Ogawa W, Yano Y and Hayashi Y: The LXXLL motif of murine forkhead
transcription factor FoxO1 mediates Sirt1-dependent transcriptional
activity. J Clin Invest. 116:2473–2483. 2006.PubMed/NCBI
|
|
36
|
Buteau J and Accili D: Regulation of
pancreatic beta-cell function by the forkhead protein FoxO1.
Diabetes Obes Metab. 9 Suppl 2:140–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kitamura YI, Kitamura T, Kruse JP, Raum
JC, Stein R, Gu W and Accili D: FoxO1 protects against pancreatic
beta cell failure through NeuroD and MafA induction. Cell Metab.
2:153–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Talchai C, Xuan S, Lin HV, Sussel L and
Accili D: Pancreatic β cell dedifferentiation as a mechanism of
diabetic β cell failure. Cell. 150:1223–1234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsuzaki H, Daitoku H, Hatta M, Aoyama H,
Yoshimochi K and Fukamizu A: Acetylation of Foxo1 alters its
DNA-binding ability and sensitivity to phosphorylation. Proc Natl
Acad Sci USA. 102:11278–11283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aggarwal G, Ramachandran V, Javeed N,
Arumugam T, Dutta S, Klee GG, Klee EW, Smyrk TC, Bamlet W, Han JJ,
et al: Adrenomedullin is up-regulated in patients with pancreatic
cancer and causes insulin resistance in β cells and mice.
Gastroenterology. 143:1510–1517.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Valerio A, Basso D, Brigato L, Ceolotto G,
Baldo G, Tiengo A and Plebani M: Glucose metabolic alterations in
isolated and perfused rat hepatocytes induced by pancreatic cancer
conditioned medium: A low molecular weight factor possibly
involved. Biochem Biophys Res Commun. 257:622–628. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chai CY, Zhang Y, Song J, Lin SC, Sun S
and Chang IW: VNN1 overexpression is associated with poor response
to preoperative chemoradiotherapy and adverse prognosis in patients
with rectal cancers. Am J Transl Res. 8:4455–4463. 2016.PubMed/NCBI
|
|
43
|
Zhang L, Li L, Gao G, Wei G, Zheng Y, Wang
C, Gao N, Zhao Y, Deng J, Chen H, et al: Elevation of GPRC5A
expression in colorectal cancer promotes tumor progression through
VNN-1 induced oxidative stress. Int J Cancer. 140:2734–2747. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Latre de Late P, El Wakil A, Jarjat M, de
Krijger RR, Heckert LL, Naquet P and Lalli E: Vanin-1 inactivation
antagonizes the development of adrenocortical neoplasia in Sf-1
transgenic mice. Endocrinology. 155:2349–2354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang C, Huang B, Sun L, Wang X, Zhou B,
Tang H and Geng W: MK8722, an AMPK activator, inhibiting carcinoma
proliferation, invasion and migration in human pancreatic cancer
cells. Biomed Pharmacother. 144:1123252021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Park TH and Kim HS: Eupatilin suppresses
pancreatic cancer cells via glucose uptake inhibition, AMPK
activation, and cell cycle arrest. Anticancer Res. 42:483–491.
2022. View Article : Google Scholar : PubMed/NCBI
|
